You are here: Industry Insights > Breast Cancer

News List

Positive EMERALD Trial Results for Elacestrant Presented at San Antonio Breast Cancer Symposium 2021 prnasia
December 13, 2021
The Menarini Group ("Menarini") and Radius Health, Inc. ("Radius") (NASDAQ: RDUS) (collectively, the "Companies") provided details on the elacestrant data from the EMERALD trial following the positive results presented today...
CONTROL study results show improved tolerability of NERLYNX® (neratinib) with all the investigated diarrhoea prophylaxis strategies prnasia
December 10, 2021
Today, the final findings of the CONTROL study1 were presented at the 2021 San Antonio Breast Cancer Symposium (SABCS). Results suggest that providing a prophylactic anti-diarrhoea medical treatment...
Nuvation Bio Announces FDA Clearance of Investigational NDA for NUV-422 for the Treatment of Advanced Breast Cancer AmericanPharmaceuticalReview
December 09, 2021
Nuvation Bio Inc. announced that the FDA has cleared its investigational new drug (IND) application to evaluate NUV-422, a cyclin-dependent kinase (CDK) 2/4/6 inhibitor, for the treatment of advanced breast cancer. The FDA accepted the Company's first ...
New Hormonal Pill May Boost Outcomes for Older Breast Cancer Patients Drugs
December 08, 2021
An experimental hormone therapy pill can effectively stall the progression of breast cancer, even in older patients whose tumors have mutated to make such therapy less effective, new trial results show.
Publication in The New England Journal of Medicine Confirms that Tens of Thousands of Women with Node-positive, Early-stage Breast Cancer Can Avoid Chemotherapy with the Oncotype DX® Test prnasia
December 03, 2021
Exact Sciences Corp. (NASDAQ: EXAS) today announced that data from the Rx for Positive Node, Endocrine Responsive Breast Cancer, or RxPONDER, trial were published in The New England Journal of Medicine.i The study...
Yakult Singapore joins virtual Pink Ribbon Walk 2021 to raise awareness for breast cancer prnasia
December 03, 2021
Yakult Singapore is taking part in the virtual edition of the Pink Ribbon Walk organised by the Breast Cancer Foundation (BCF) from 1st to 31st December 2021.
Lynparza Granted Priority Review in the US for Breast Cancer AmericanPharmaceuticalReview
December 01, 2021
AstraZeneca’s supplemental New Drug Application (sNDA) for Lynparza (olaparib) has been accepted and granted Priority Review in the US for the adjuvant treatment of patients with BRCA-mutated (BRCAm) HER2-negative high-risk early breast cancer who have...
Cleveland Clinic launches first-of-its kind preventive breast cancer vaccine study WorldPharmaNews
November 03, 2021
Cleveland Clinic researchers have opened a novel study for a vaccine aimed at eventually preventing triple-negative breast cancer, the most aggressive and lethal form of the disease.
Bigo Live Continues its Partnership with Living Beyond Breast Cancer(R) to Honor Breast Cancer Awareness Month prnasia
October 19, 2021
Bigo Live, a global leader in live streaming, today announced it's made a $10,000 donation to Living Beyond Breast Cancer (LBBC). LBBC is a national nonprofit that provides people with trusted information...
NICE recommends Eli Lilly’s breast cancer drug Verzenios pharmatimes
August 13, 2021
Draft NICE guidance has recommended Eli Lilly’s twice-daily pill Verzenios (abemaciclib) as an option for adults with a type of breast cancer called hormone receptor-positive, HER2-negative breast cancer which has spread to other parts of the body.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 26 27 Next page